| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.24 | 6e-06 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.24 | 0.07 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-05 |